Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies

J Clin Oncol. 2020 Oct 10;38(29):3363-3366. doi: 10.1200/JCO.20.00434. Epub 2020 Jun 30.
No abstract available

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Androgen Antagonists / therapeutic use
  • Aromatase Inhibitors / adverse effects*
  • Aromatase Inhibitors / therapeutic use
  • Bone Density / drug effects
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Female
  • Gonadotropin-Releasing Hormone / adverse effects*
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Male
  • Osteoporotic Fractures / chemically induced
  • Osteoporotic Fractures / etiology*
  • Osteoporotic Fractures / pathology
  • Predictive Value of Tests
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology

Substances

  • Androgen Antagonists
  • Aromatase Inhibitors
  • Gonadotropin-Releasing Hormone